Dow Down0.17% Nasdaq Down0.28%

United Therapeutics Corporation (UTHR)

-NasdaqGS
128.65 Down 4.06(3.06%) 4:00PM EDT
|After Hours : 128.65 Up 0.00 (0.00%) 4:41PM EDT
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingJun 30, 2014Mar 31, 2014Dec 31, 2013Sep 30, 2013
Total Revenue 322,802   289,403   289,017   302,225  
Cost of Revenue38,709  30,600  38,778  30,716  
Gross Profit 284,093   258,803   250,239   271,509  
Operating Expenses
Research Development39,742  12,448  121,552  72,749  
Selling General and Administrative68,031  30,215  157,178  94,111  
Non Recurring -   -   -   -  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss 176,320   216,140   (28,491) 104,649  
Income from Continuing Operations
Total Other Income/Expenses Net1,459  1,686  1,423  1,070  
Earnings Before Interest And Taxes177,779  217,826  (27,068)105,719  
Interest Expense4,746  4,610  4,562  4,540  
Income Before Tax173,033  213,216  (31,630)101,179  
Income Tax Expense61,181  75,692  (1,316)38,494  
Minority Interest -   -   -   -  
Net Income From Continuing Ops111,852  137,524  (30,314)62,685  
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income 111,852   137,524   (30,314) 62,685  
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares 111,852   137,524   (30,314) 62,685  

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.